Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 325 of 6351
-
New injection combo takes aim at tough skin cancers
Disease control Recruiting nowOpen-label, single-arm, multicenter study in patients with locally advanced, histologically confirmed Cutaneous Squamous Cell Carcinoma (LacSCC) amenable to intratumoral injection, who have progressed on or are intolerant to Immune Checkpoint Inhibitor (ICI). The primary objectiv…
Phase 2 • Sponsor: Philogen S.p.A. • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
Experimental vaccine cocktail targets rare liver cancer in early trial
Disease control Not yet recruitingThe purpose of this study is to determine whether the combination of a neoantigen vaccine targeting the DNAJB1-PRKACA fusion kinase in combination with DRP-104, Nivolumab and Ipilimumab is safe and yields a clinically compelling antitumor activity measured as based on objective r…
Phase 1 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins • Aim: Disease control
Last updated Aug 27, 2026 00:00 UTC
-
New hope for Wake-Up stroke patients: drug may boost recovery
Disease control Not yet recruitingThe benefit of intravenous tenecteplase for acute ischemic stroke with unknown time of onset, e.g. wake-up stroke, remains uncertain. This randomized study aims to assess the efficacy and safety of intravenous tenecteplase following non-contrast CT screening for acute ischemic st…
Phase 3 • Sponsor: First Affiliated Hospital of Guangxi Medical University • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
New pill aims to curb focal seizures in adults
Disease control Recruiting nowThis is a clinical research study for an investigational drug called RAP-219 in adult participants with focal seizures. This study is being conducted to determine if RAP-219 is safe and effective in reducing focal seizure frequency.
Phase 3 • Sponsor: Rapport Therapeutics Inc. • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Water jet surgery could offer new option for prostate cancer patients
Disease control Not yet recruitingThe WATER IV study is a multicenter, prospective, randomized clinical trial that aims to evaluate the safety and efficacy of Aquablation therapy in men with localized prostate cancer.
Sponsor: PROCEPT BioRobotics • Aim: Disease control
Last updated Aug 06, 2026 00:00 UTC
-
Digital sleep therapy aims to stop depression before it starts in young adults
Prevention Not yet recruitingDepression is a leading cause of global disease burden, poor quality of life, disability and suicide, and commonly occurs in adolescence and early adulthood. Insomnia and circadian factors were regarded as potential targets for preventing worsening of depressive symptoms. Additio…
Sponsor: Chinese University of Hong Kong • Aim: Prevention
Last updated Sep 05, 2026 00:00 UTC
-
Peer support and family engagement could curb youth suicide in nepal
Disease control Not yet recruitingSouth Asia has the highest suicide rate in the world with important risk profile differences from high-income settings. Investigators will conduct formative research to co-design a package of brief interventions and implementation strategies to prevent youth-suicide and then test…
Sponsor: Yale University • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
Custom-Made vaccine aims to boost immune attack on kidney tumors
Disease control Not yet recruitingThis is a Phase I, single-center, open-label, single-arm clinical trial to evaluate the safety and efficacy of personalized neoantigen polyepitope peptide vaccine combined with pembrolizumab in patients with advanced, recurrent or refractory renal cell carcinoma (RCC). Backgroun…
Phase 1 • Sponsor: Jian Lin • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
Triple-Drug combo aims to improve diabetes control and weight loss
Disease control Not yet recruitingThis Phase 2a, randomized, double-blind, active-controlled study will evaluate the safety, tolerability, and preliminary efficacy of TriGlytza®-01 compared with metformin in adults with Type 2 diabetes inadequately controlled despite metformin therapy. Participants will be random…
Phase 2 • Sponsor: Myopharm Limited • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
Bedside flu shot for heart patients: a simple strategy to save lives?
Prevention Not yet recruitingThe aim of this study is to evaluate the effect of offering intrahospital influenza vaccination as an adjunct to active counseling during the index hospitalization to adult patients hospitalized for acute coronary syndrome (ACS) or congestive heart failure (CHF), compared with ac…
Sponsor: Stephan Baldus • Aim: Prevention
Last updated Jul 25, 2026 00:00 UTC
-
Can an AI chatbot ease fertility worries for young cancer survivors?
Symptom relief Not yet recruitingReproductive health has emerged as a critical yet overlooked concern among Adolescent and Young Adult (AYA) cancer survivors, given their compromised potential for biological parenthood in prime childbearing years. Large language models (LLMs) offer a promising solution to bridge…
Sponsor: The Hong Kong Polytechnic University • Aim: Symptom relief
Last updated Aug 05, 2026 00:00 UTC
-
Can dance beat pilates for lasting Weight-Loss motivation?
Disease control Not yet recruitingPurpose of the Study: Regular physical activity is key in managing overweight and obesity, but keeping up with a program can be challenging. The main purpose of this study is to compare how well women with overweight or obesity stick to (adhere to) a 10-week dance-based exercise…
Sponsor: Pamukkale University • Aim: Disease control
Last updated Aug 06, 2026 00:00 UTC
-
Can a daily nudge cut deadly bloodstream infections?
Prevention Not yet recruitingThis study evaluates a daily electronic health record (EHR) alert designed to reduce unnecessary central venous catheter (CVC) use among hospitalized adults. The alert identifies patients with an active CVC and no documented indication, prompting the first-contact provider to doc…
Sponsor: NYU Langone Health • Aim: Prevention
Last updated Aug 07, 2026 00:00 UTC
-
Can a nerve block and a sedative replace opioids in heart surgery?
Disease control Not yet recruitingEnhanced Recovery After Surgery (ERAS) protocols have revolutionized perioperative management by implementing evidence-based, patient-centered strategies that improve clinical outcomes, shorten hospital length of stay, and reduce healthcare costs. In cardiac surgery, ERAS has fac…
Sponsor: Assiut University • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
Massage therapy may offer a Drug-Free path to better sleep
Symptom relief Not yet recruitingThis randomized controlled trial will investigate the effects of connective tissue massage on insomnia severity, objective and subjective sleep outcomes, and stress- and autonomic-related biomarkers in adults with chronic insomnia. Chronic insomnia is a common sleep disorder char…
Sponsor: Saglik Bilimleri Universitesi • Aim: Symptom relief
Last updated Aug 20, 2026 00:00 UTC
-
Can a Dual-Action antibody outsmart advanced solid tumors?
Disease control Not yet recruitingThis study is an open-label, multicenter, dose-escalation and expansion, non-randomized Phase I clinical study to evaluate the safety, tolerability, pharmacokinetic characteristics, and preliminary efficacy of SI-B036 bispecific antibody injection in patients with locally advance…
Phase 1 • Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC
-
A Non-Opioid painkiller may cut opioid use after knee surgery
Symptom relief Not yet recruitingThe purpose of this research is to see if a person having an outpatient total knee replacement will have a difference in their pain and the amount of pain medication (opioids) used after discharge if they are given suzetrigine (a non-opioid pain medicine, also known as Journavx®)…
Phase 4 • Sponsor: Endeavor Health • Aim: Symptom relief
Last updated Sep 04, 2026 00:00 UTC
-
Could a trusted friend or family member enhance PTSD recovery?
Symptom relief Not yet recruitingThe purpose of this study is to determine whether adding a Support-Person Module to Trauma-Informed Goal Management Training (TIGMT) can improve engagement and recovery among individuals who have experienced traumatic events and are currently experiencing post-traumatic stress. P…
Sponsor: McMaster University • Aim: Symptom relief
Last updated Sep 03, 2026 00:00 UTC
-
Can a pill mimic the Body's appetite hormone to fight obesity?
Disease control Not yet recruitingThis is a multicenter, randomized, double-blind, placebo-controlled Phase 1b clinical study. All trial participants are required to use TQF3250 capsules or placebo. The aim is to evaluate the safety, tolerability, pharmacokinetic characteristics, and preliminary efficacy of multi…
Phase 1 • Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
Can a 15-Day wearable sensor keep blood sugar on target?
Disease control Not yet recruitingThis clinical study evaluates the GX-01S Continuous Glucose Monitoring (CGM) System in adults with Type 1 or Type 2 diabetes. CGM systems measure glucose levels continuously throughout the day, providing real-time information that can help patients manage their diabetes more effe…
Sponsor: MicroTech Medical(Hangzhou)Co.,Ltd. • Aim: Disease control
Last updated Sep 10, 2026 03:00 UTC